{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:59:16Z","timestamp":1793397556610,"version":"4.5.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Chemokine signaling networks have emerged as pivotal regulators of skeletal homeostasis, integrating inflammation, angiogenesis, and immune activation with the processes of bone remodeling and regeneration. Recent evidence demonstrates that dysregulated chemokine\u2013receptor interactions, including CCL2\/CCR2, CCL5\/CCR5, and CX3CL1\/CX3CR1, disrupt the equilibrium between osteogenesis and osteoclastogenesis, thereby contributing to the pathogenesis of osteoporosis, osteoarthritis, multiple myeloma, and bone metastasis. This review synthesizes current insights into how chemokine-mediated signaling cascades intersect with canonical pathways such as JAK\/STAT3, NF-\u03baB, PI3K\/Akt, and Wnt\/\u03b2-catenin to coordinate cellular communication within the bone microenvironment. Furthermore, it highlights recent progress in therapeutic strategies targeting chemokine axes to mitigate inflammatory bone loss and promote tissue regeneration, while addressing translational barriers including receptor redundancy, context-dependent specificity, and limited\n                    <jats:italic>in vivo<\/jats:italic>\n                    validation. By positioning chemokines as dynamic mediators at the interface of the immune and skeletal systems, this review establishes a conceptual foundation for the development of precision therapeutics aimed at restoring bone homeostasis and treating skeletal disorders.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2025.1667440","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:36Z","timestamp":1764739236000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting chemokine signaling networks for therapeutics in skeletal disorders"],"prefix":"10.3389","volume":"16","author":[{"given":"Wenjie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1222129","article-title":"The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02182","article-title":"Chemokines in physiological and pathological bone remodeling","volume":"10","author":"Brylka","year":"2019","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"106314","DOI":"10.1016\/j.intimp.2020.106314","article-title":"The role of chemokines and chemokine receptors in multiple sclerosis","volume":"83","author":"Cui","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12974-022-02676-8","article-title":"Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K\/Akt pathway","volume":"19","author":"Tian","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.02.017","article-title":"CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9\/Th22-related markers in the brain and periphery","volume":"144","author":"Al-Mazroua","year":"2022","journal-title":"Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/biom14121541","article-title":"CXCL13 as a biomarker: background and utility in multiple sclerosis","volume":"14","author":"Pachner","year":"2024","journal-title":"Biomolecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12987-023-00441-4","article-title":"The choroid plexus acts as an immune cell reservoir and brain entry site in experimental autoimmune encephalomyelitis","volume":"20","author":"Lazarevic","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1189348","article-title":"CX3CL1\/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting","volume":"17","author":"Wang","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/antib12020030","article-title":"CCR6 as a potential target for therapeutic antibodies for the treatment of inflammatory diseases","volume":"12","author":"G\u00f3mez-Melero","year":"2023","journal-title":"Antibodies (Basel Switzerland)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10238-024-01508-8","article-title":"CXCL13: a common target for immune-mediated inflammatory diseases","volume":"24","author":"Hui","year":"2024","journal-title":"Clin Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.08.005","article-title":"Expression profile of cytokines and chemokines in osteoarthritis patients: Proinflammatory roles for CXCL8 and CXCL11 to chondrocytes","author":"Shi","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1110765","article-title":"JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens","volume":"11","author":"Hu","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1069057","article-title":"The potential roles of JAK\/STAT signaling in the progression of osteoarthritis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/1535370220974933","article-title":"FOXM1 activates JAK1\/STAT3 pathway in human osteoarthritis cartilage cell inflammatory reaction","volume":"246","author":"Zeng","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11706","article-title":"Mechanisms of JAK\u2212STAT signaling pathway mediated by CXCL8 gene silencing on epithelial\u2212mesenchymal transition of human cutaneous melanoma cells","volume":"20","author":"Hu","year":"2020","journal-title":"Oncol Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ijms25010381","article-title":"Chemokines in cartilage regeneration and degradation: new insights","volume":"25","author":"Edderkaoui","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12964-023-01094-4","article-title":"Regulation and therapy, the role of JAK2\/STAT3 signaling pathway in OA: a systematic review","volume":"21","author":"Chen","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4756","article-title":"STAT3\/mitophagy axis coordinates macrophage NLRP3 inflammasome activation and inflammatory bone loss","volume":"38","author":"Zhu","year":"2023","journal-title":"J Bone Miner Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e13518","DOI":"10.1111\/cpr.13518","article-title":"Endothelial Stat3 activation promotes osteoarthritis development","volume":"56","author":"Li","year":"2023","journal-title":"Cell Prolif"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2023.12.004","article-title":"Myostatin and CXCL11 promote nervous tissue macrophages to maintain osteoarthritis pain","volume":"116","author":"Martin Gil","year":"2023","journal-title":"Brain Behavior Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803832","article-title":"Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C\/EBP beta, and RNA polymerase II binding to the CXCL8 promoter","volume":"183","author":"John","year":"2009","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"eabh4050","DOI":"10.1126\/sciadv.abh4050","article-title":"Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8","volume":"8","author":"Walle","year":"2022","journal-title":"Sci Adv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1069057","article-title":"The Potential Roles of Jak\/Stat Signaling in the Progression of Osteoarthritis","volume":"13","author":"Zhou","year":"2022","journal-title":"Frontiers in Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.3390\/ijms19092607","article-title":"Inhibitory effect of alisma canaliculatum ethanolic extract on NF-\u03baB-dependent CXCR3 and CXCL10 expression in TNF\u03b1-exposed MDA-MB-231 breast cancer cells","volume":"19","author":"Choi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","article-title":"Targeting strategies for bone diseases: signaling pathways and clinical studies","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41413-024-00346-4","article-title":"Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system","volume":"12","author":"Mi","year":"2024","journal-title":"Bone Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7555\/JBR.31.20150166","article-title":"CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients","volume":"31","author":"Fatehi","year":"2017","journal-title":"J Biomed Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.03.009","article-title":"The role of dendritic cells derived osteoclasts in bone destruction diseases","volume":"8","author":"Wang","year":"2021","journal-title":"Genes Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1022688","article-title":"The role of CXCR3 and its ligands in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"20211272","DOI":"10.1259\/bjr.20211272","article-title":"Imaging CXCR4 receptors expression for staging multiple myeloma by using (68)Ga-Pentixafor PET\/CT: comparison with (18)F-FDG PET\/CT","volume":"95","author":"Shekhawat","year":"2022","journal-title":"Br J Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1361-y","article-title":"Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance","volume":"62","author":"Zhang","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.3390\/ijms22126208","article-title":"Myeloma bone disease: A comprehensive review","volume":"22","author":"Mukkamalla","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.3390\/jcm12134440","article-title":"Dynamics of bone disease biomarkers dickkopf-1 and sclerostin in patients with multiple myeloma","volume":"12","author":"Gerov","year":"2023","journal-title":"J Clin Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05452-w","article-title":"Serum concentration of dickkopf-related protein 1 (DKK1) in psoriatic arthritis in the context of bone remodelling","volume":"43","author":"Biedron","year":"2023","journal-title":"Rheumatol Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0380","article-title":"Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index","volume":"102","author":"Terpos","year":"2003","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00774-023-01403-4","article-title":"Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents","volume":"41","author":"Teramachi","year":"2023","journal-title":"J Bone Miner Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.3390\/cancers15235562","article-title":"Circulating sRANKL, periostin, and osteopontin as biomarkers for the assessment of activated osteoclastogenesis in myeloma related bone disease","volume":"15","author":"Gerov","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.3390\/ijms21103723","article-title":"Fractalkine\/CX3CL1 in neoplastic processes","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"107989","DOI":"10.1016\/j.pharmthera.2021.107989","article-title":"CX3CL1\/CX3CR1 signaling targets for the treatment of neurodegenerative diseases","volume":"231","author":"Subbarayan","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.254268","article-title":"CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease","volume":"286","author":"Cho","year":"2011","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11250","article-title":"Fractalkine\/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1\/PI3K\/Akt\/NF-kappaB pathway in human osteosarcoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25577","article-title":"Involvement of CX3CL1 in the migration of osteoclast precursors across osteoblast layer stimulated by interleukin-1ss","volume":"232","author":"Matsuura","year":"2017","journal-title":"J Cell Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7570452","DOI":"10.1155\/2019\/7570452","article-title":"Role of CX3CL1\/CX3CR1 signaling axis activity in osteoporosis","volume":"2019","author":"Wojdasiewicz","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7150\/jca.47022","article-title":"Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review","volume":"12","author":"Rivas-Fuentes","year":"2021","journal-title":"J Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900665","article-title":"Osteoclasts Derive Predominantly from Bone Marrow-Resident CX(3)CR1(+) Precursor Cells in Homeostasis, whereas Circulating CX(3)CR1(+) Cells Contribute to Osteoclast Development during Fracture Repair","volume":"204","author":"Novak","year":"2020","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e54493","DOI":"10.7554\/eLife.54493","article-title":"Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1","volume":"9","author":"Madel","year":"2020","journal-title":"eLife"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2016.1139287","article-title":"Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and\/or hypoxic stimuli","volume":"10","author":"Yu","year":"2016","journal-title":"Cell Adh Migr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e90518","DOI":"10.1371\/journal.pone.0090518","article-title":"Hypoxia promotes migration and induces CXCR4 expression via HIF-1alpha activation in human osteosarcoma","volume":"9","author":"Guo","year":"2014","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"561098","DOI":"10.1155\/2013\/561098","article-title":"Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1\/CXCR4 axis","volume":"2013","author":"Marquez-Curtis","year":"2013","journal-title":"BioMed Res Int"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-011-1097-z","article-title":"SDF-1\/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion","volume":"2","author":"Liu","year":"2011","journal-title":"Protein Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e54077","DOI":"10.1371\/journal.pone.0054077","article-title":"SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.expneurol.2018.09.005","article-title":"Oncostatin M-induced upregulation of SDF-1 improves Bone marrow stromal cell migration in a rat middle cerebral artery occlusion stroke model","volume":"313","author":"Han","year":"2019","journal-title":"Exp Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"963689720929992","DOI":"10.1177\/0963689720929992","article-title":"SDF-1\/CXCR4 augments the therapeutic effect of bone marrow mesenchymal stem cells in the treatment of lipopolysaccharide-induced liver injury by promoting their migration through PI3K\/akt signaling pathway","volume":"29","author":"Xiu","year":"2020","journal-title":"Cell Transplant"},{"key":"B57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","article-title":"Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease","volume":"12","author":"Hu","year":"2024","journal-title":"Bone Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12611","article-title":"R-spondin 2 promotes osteoblastic differentiation of immature human periodontal ligament cells through the Wnt\/beta-catenin signaling pathway","volume":"54","author":"Arima","year":"2019","journal-title":"J Periodontal Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"101026","DOI":"10.1016\/j.gendis.2023.04.042","article-title":"The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities","volume":"11","author":"Yu","year":"2024","journal-title":"Genes Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s42003-025-07765-x","article-title":"Mapk7 enhances osteogenesis and suppresses adipogenesis by activating Lrp6\/\u03b2-catenin signaling axis in mesenchymal stem cells","volume":"8","author":"Li","year":"2025","journal-title":"Commun Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"B62","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.immuni.2019.01.009","article-title":"Chemokine receptor redundancy and specificity are context dependent","volume":"50","author":"Dyer","year":"2019","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e31226","DOI":"10.1371\/journal.pone.0031226","article-title":"CXCR4 expression in prostate cancer progenitor cells","volume":"7","author":"Dubrovska","year":"2012","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/genes14020408","article-title":"Chemokine regulation in temporomandibular joint disease: A comprehensive review","volume":"14","author":"Qiao","year":"2023","journal-title":"Genes (Basel)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1038\/emm.2017.100","article-title":"Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21","volume":"49","author":"Lee","year":"2017","journal-title":"Exp Mol Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3492","article-title":"Tumor-induced stromal reprogramming drives lymph node transformation","volume":"17","author":"Riedel","year":"2016","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0065","article-title":"Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts","volume":"146","author":"Yano","year":"2005","journal-title":"Endocrinology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2147\/CCIDE.S417783","article-title":"Reduction of inflammatory RANTES\/CCL5 serum levels by surgery in patients with bone marrow defects of the jawbone","volume":"15","author":"Diederich","year":"2023","journal-title":"Clinical Cosmetic Investigational Dentistry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/imm.12618","article-title":"Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis","volume":"148","author":"Aalinkeel","year":"2016","journal-title":"Immunology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1667440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:37Z","timestamp":1764739237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1667440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":71,"alternative-id":["10.3389\/fendo.2025.1667440"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1667440","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"1667440"}}